×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Metastatic Breast Cancer

Being cured and being healed are two different things, and one can happen without the other.
Lauren M. Green
People across the nation are participating in the Metastatic Breast Cancer (MBC) Project to help researchers steer the approach in fighting the disease.  
Anita T. Shaffer
Recent findings may make way for a less expensive treatment option for patients with metastatic breast cancer. 
Silas Inman
Postmenopausal women with locally-advanced or metastatic HR-positive breast cancer benefited from the use of Faslodex (fulvestrant) as a frontline treatment. 
Ann Silberman
Five years ago, I was stricken with metastatic breast cancer. This heartbreaking diagnosis came not long after I finished treatment for early stage, HER2+ cancer.
Andrew J. Roth
O’Shaughnessy highlighted a group of agents that encompasses entirely new ideas and new options for patients as well as novel avenues from follow-up data from clinical trials.
Andrew J. Roth
CURE speaks with Joyce OShaughnessy, MD, on the rise of treatment options for patients with estrogen receptor (ER)-positive metastatic breast cancer.
Debu Tripathy
In this issue of CURE magazine, we review the current approaches for the evaluation and treatment of metastatic breast cancer, and what the future holds.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable